FY2024 EPS Estimates for Integer Increased by Zacks Research

Integer Holdings Co. (NYSE:ITGR) – Zacks Research lifted their FY2024 earnings per share (EPS) estimates for shares of Integer in a report released on Thursday, November 14th. Zacks Research analyst D. Dey now anticipates that the medical equipment provider will post earnings of $5.32 per share for the year, up from their prior forecast of $5.28. The consensus estimate for Integer’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Integer’s Q4 2024 earnings at $1.45 EPS, Q1 2025 earnings at $1.30 EPS, Q2 2025 earnings at $1.45 EPS, Q4 2025 earnings at $1.69 EPS, FY2025 earnings at $5.99 EPS, Q1 2026 earnings at $1.63 EPS and Q2 2026 earnings at $1.57 EPS.

A number of other equities research analysts have also recently weighed in on ITGR. KeyCorp upped their price objective on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Benchmark boosted their price objective on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. Piper Sandler restated an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a research note on Friday, October 25th. Truist Financial decreased their price objective on Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Citigroup boosted their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $139.75.

Integer Stock Down 1.2 %

Shares of Integer stock opened at $133.18 on Monday. Integer has a 1 year low of $84.75 and a 1 year high of $140.91. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The stock has a market cap of $4.47 billion, a price-to-earnings ratio of 41.10, a PEG ratio of 1.91 and a beta of 1.09. The firm’s 50-day moving average is $129.20 and its two-hundred day moving average is $122.66.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.27 earnings per share.

Institutional Investors Weigh In On Integer

Institutional investors have recently modified their holdings of the business. Contravisory Investment Management Inc. raised its position in Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares during the period. Huntington National Bank lifted its stake in Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares in the last quarter. Quest Partners LLC boosted its holdings in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC increased its stake in Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after buying an additional 142 shares in the last quarter. Finally, Innealta Capital LLC acquired a new position in shares of Integer during the second quarter valued at approximately $110,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.